Prevalence of VEXAS Syndrome Identified in U.S. Health System

WEDNESDAY, Jan. 25, 2023 -- The prevalence and clinical manifestations of UBA1 variants associated with VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome have been identified in a single health system, according to a study...

Source: Drugs.com - Pharma News - January 25, 2023 Category: Pharmaceuticals Source Type: news